The cardiac effects of hydroxychloroquine in immune-mediated rheumatologic diseases

被引：0
|
作者：
Weidman-Evans, Emily [1 ]
Porter, Mandy [1 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, PA Program, New Orleans, LA 70112 USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2022年 / 35卷 / 04期
关键词：
hydroxychloroquine; cardiac; adverse reactions; rheumatoid arthritis; systemic lupus erythematosus; chloroquine; CARDIOVASCULAR-DISEASE; ARTHRITIS; CHLOROQUINE; RISK;
D O I：
10.1097/01.JAA.0000805852.13262.54
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hydroxychloroquine, when used to treat patients with rheumatoid arthritis or systemic lupus erythematosus, has been found to reduce cardiovascular disease (CVD). The drug also has been associated with cardiac adverse reactions such as conduction abnormalities. This article reviews the reduction of CVD and the cardiac adverse reactions associated with hydroxychloroquine.
引用
收藏
页码：51 / 53
页数：3
相关论文
共 50 条
  • [1] NON-ADHERENCE IN RHEUMATOLOGIC IMMUNE-MEDIATED DISEASES
    Rodriguez-Alarceni, A.
    Carballo, N.
    Rio, L.
    Perez, C.
    Gonzalez-Colominas, E.
    Durand, X.
    Monfort, J.
    Grau-Cerrato, S.
    Ferrandez-Quirantel, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1132 - 1132
  • [2] Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
    Milena A. Gianfrancesco
    Gabriela Schmajuk
    Sarah Haserodt
    Laura Trupin
    Zara Izadi
    Kashif Jafri
    Stephen Shiboski
    Marina Sirota
    R. Adams Dudley
    Jinoos Yazdany
    Rheumatology International, 2017, 37 : 1611 - 1618
  • [3] Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
    Gianfrancesco, Milena A.
    Schmajuk, Gabriela
    Haserodt, Sarah
    Trupin, Laura
    Izadi, Zara
    Jafri, Kashif
    Shiboski, Stephen
    Sirota, Marina
    Dudley, R. Adams
    Yazdany, Jinoos
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (10) : 1611 - 1618
  • [4] Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
    Milena A. Gianfrancesco
    Gabriela Schmajuk
    Sarah Haserodt
    Laura Trupin
    Zara Izadi
    Kashif Jafri
    Stephen Shiboski
    Marina Sirota
    R. Adams Dudley
    Jinoos Yazdany
    Rheumatology International, 2018, 38 : 319 - 319
  • [5] Causal effects of the microbiota on immune-mediated diseases
    Round, June L.
    Palm, Noah W.
    SCIENCE IMMUNOLOGY, 2018, 3 (20)
  • [6] Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases
    Balanescu, Andra-Rodica
    Bojinca, Violeta Claudia
    Bojinca, Mihai
    Donisan, Teodora
    Balanescu, Serban Mihai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (02) : 1024 - 1029
  • [7] The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases
    Qiu, Feifei
    Lin, Jingru
    Huang, Xiaofei
    Yang, Bin
    Lu, Weihui
    Dai, Zhenhua
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [8] Metformin and Its Immune-Mediated Effects in Various Diseases
    Nojima, Ichiro
    Wada, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [9] Immune-Mediated Lung Diseases
    Jacobs, Kathleen
    Kligerman, Seth
    SEMINARS IN ULTRASOUND CT AND MRI, 2019, 40 (03) : 213 - 228
  • [10] IMMUNOTHERAPY OF IMMUNE-MEDIATED DISEASES
    PANAYI, GS
    KINGSLEY, GH
    LANCHBURY, JSS
    QUARTERLY JOURNAL OF MEDICINE, 1992, 83 (303): : 489 - 495
12345